Cargando…

Structure and Dynamics Guiding Design of Antibody Therapeutics and Vaccines

Antibodies and other new antibody-like formats have emerged as one of the most rapidly growing classes of biotherapeutic proteins. Understanding the structural features that drive antibody function and, consequently, their molecular recognition is critical for engineering antibodies. Here, we presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández-Quintero, Monica L., Pomarici, Nancy D., Fischer, Anna-Lena M., Hoerschinger, Valentin J., Kroell, Katharina B., Riccabona, Jakob R., Kamenik, Anna S., Loeffler, Johannes R., Ferguson, James A., Perrett, Hailee R., Liedl, Klaus R., Han, Julianna, Ward, Andrew B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594513/
https://www.ncbi.nlm.nih.gov/pubmed/37873864
http://dx.doi.org/10.3390/antib12040067
_version_ 1785124667778924544
author Fernández-Quintero, Monica L.
Pomarici, Nancy D.
Fischer, Anna-Lena M.
Hoerschinger, Valentin J.
Kroell, Katharina B.
Riccabona, Jakob R.
Kamenik, Anna S.
Loeffler, Johannes R.
Ferguson, James A.
Perrett, Hailee R.
Liedl, Klaus R.
Han, Julianna
Ward, Andrew B.
author_facet Fernández-Quintero, Monica L.
Pomarici, Nancy D.
Fischer, Anna-Lena M.
Hoerschinger, Valentin J.
Kroell, Katharina B.
Riccabona, Jakob R.
Kamenik, Anna S.
Loeffler, Johannes R.
Ferguson, James A.
Perrett, Hailee R.
Liedl, Klaus R.
Han, Julianna
Ward, Andrew B.
author_sort Fernández-Quintero, Monica L.
collection PubMed
description Antibodies and other new antibody-like formats have emerged as one of the most rapidly growing classes of biotherapeutic proteins. Understanding the structural features that drive antibody function and, consequently, their molecular recognition is critical for engineering antibodies. Here, we present the structural architecture of conventional IgG antibodies alongside other formats. We emphasize the importance of considering antibodies as conformational ensembles in solution instead of focusing on single-static structures because their functions and properties are strongly governed by their dynamic nature. Thus, in this review, we provide an overview of the unique structural and dynamic characteristics of antibodies with respect to their antigen recognition, biophysical properties, and effector functions. We highlight the numerous technical advances in antibody structure prediction and design, enabled by the vast number of experimentally determined high-quality structures recorded with cryo-EM, NMR, and X-ray crystallography. Lastly, we assess antibody and vaccine design strategies in the context of structure and dynamics.
format Online
Article
Text
id pubmed-10594513
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105945132023-10-25 Structure and Dynamics Guiding Design of Antibody Therapeutics and Vaccines Fernández-Quintero, Monica L. Pomarici, Nancy D. Fischer, Anna-Lena M. Hoerschinger, Valentin J. Kroell, Katharina B. Riccabona, Jakob R. Kamenik, Anna S. Loeffler, Johannes R. Ferguson, James A. Perrett, Hailee R. Liedl, Klaus R. Han, Julianna Ward, Andrew B. Antibodies (Basel) Review Antibodies and other new antibody-like formats have emerged as one of the most rapidly growing classes of biotherapeutic proteins. Understanding the structural features that drive antibody function and, consequently, their molecular recognition is critical for engineering antibodies. Here, we present the structural architecture of conventional IgG antibodies alongside other formats. We emphasize the importance of considering antibodies as conformational ensembles in solution instead of focusing on single-static structures because their functions and properties are strongly governed by their dynamic nature. Thus, in this review, we provide an overview of the unique structural and dynamic characteristics of antibodies with respect to their antigen recognition, biophysical properties, and effector functions. We highlight the numerous technical advances in antibody structure prediction and design, enabled by the vast number of experimentally determined high-quality structures recorded with cryo-EM, NMR, and X-ray crystallography. Lastly, we assess antibody and vaccine design strategies in the context of structure and dynamics. MDPI 2023-10-18 /pmc/articles/PMC10594513/ /pubmed/37873864 http://dx.doi.org/10.3390/antib12040067 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Fernández-Quintero, Monica L.
Pomarici, Nancy D.
Fischer, Anna-Lena M.
Hoerschinger, Valentin J.
Kroell, Katharina B.
Riccabona, Jakob R.
Kamenik, Anna S.
Loeffler, Johannes R.
Ferguson, James A.
Perrett, Hailee R.
Liedl, Klaus R.
Han, Julianna
Ward, Andrew B.
Structure and Dynamics Guiding Design of Antibody Therapeutics and Vaccines
title Structure and Dynamics Guiding Design of Antibody Therapeutics and Vaccines
title_full Structure and Dynamics Guiding Design of Antibody Therapeutics and Vaccines
title_fullStr Structure and Dynamics Guiding Design of Antibody Therapeutics and Vaccines
title_full_unstemmed Structure and Dynamics Guiding Design of Antibody Therapeutics and Vaccines
title_short Structure and Dynamics Guiding Design of Antibody Therapeutics and Vaccines
title_sort structure and dynamics guiding design of antibody therapeutics and vaccines
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594513/
https://www.ncbi.nlm.nih.gov/pubmed/37873864
http://dx.doi.org/10.3390/antib12040067
work_keys_str_mv AT fernandezquinteromonical structureanddynamicsguidingdesignofantibodytherapeuticsandvaccines
AT pomaricinancyd structureanddynamicsguidingdesignofantibodytherapeuticsandvaccines
AT fischerannalenam structureanddynamicsguidingdesignofantibodytherapeuticsandvaccines
AT hoerschingervalentinj structureanddynamicsguidingdesignofantibodytherapeuticsandvaccines
AT kroellkatharinab structureanddynamicsguidingdesignofantibodytherapeuticsandvaccines
AT riccabonajakobr structureanddynamicsguidingdesignofantibodytherapeuticsandvaccines
AT kamenikannas structureanddynamicsguidingdesignofantibodytherapeuticsandvaccines
AT loefflerjohannesr structureanddynamicsguidingdesignofantibodytherapeuticsandvaccines
AT fergusonjamesa structureanddynamicsguidingdesignofantibodytherapeuticsandvaccines
AT perretthaileer structureanddynamicsguidingdesignofantibodytherapeuticsandvaccines
AT liedlklausr structureanddynamicsguidingdesignofantibodytherapeuticsandvaccines
AT hanjulianna structureanddynamicsguidingdesignofantibodytherapeuticsandvaccines
AT wardandrewb structureanddynamicsguidingdesignofantibodytherapeuticsandvaccines